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Negative pressure wound therapy in a chronic
radiation dermatitis of the scalp.
Tomasz Banasiewicz, Wojciech Francuzik
CASE REPORT
Abstract— The adverse reactions of late tissue damage in
irradiated patients may range from bothersome symptoms that
negatively affect their quality of life to severe life-threatening
complications. We describe the case of a female patient, EM,
54 years old who presented with chronic radioation dermatitis
on her scalp following radiotherapy (60 Gy in 30 fractions over
6 weeks) for a meningioma of the right frontal region.
We decided to introduce the negative pressure wound therapy
(NPWT) with a portable AvelleTM system (Convatec; UK) in a
continuous therapy mode with -80 mmHg vacuum. The dressing
was subsequently applied directly on the skin of the skull and
braced with extra adhesive strips and changed every 3 days (3
changes in total). During the therapy we didn’t observed any
side-effects or complications, system was well tolerated by the
patient and lead to the improvement of the wound promoting
the granulation and decreasing the exudate from the wound.
Keywords—venous ulcers, negative pressure wound therapy,
chronic wound, chronic venous insufficiency, skin graft, silver,
pain
I. INTRODUCTION
SEVERE skin, soft tissue and bone infections are delayedcomplications of irradiation of the skull in the course
skull and brain tumor radiotherapy.1 The adverse reactions
of late tissue damage in irradiated patients may range from
bothersome symptoms that negatively affect their quality
of life to severe life-threatening complications.2 In patients
with advanced necrosis it may lead to severe tissue and
bone defects, with vast exposure of the dura mater surface
and severe infections.3 Up to 95% of patients who undergo
irradiation develop adverse skin lesions.4 Treatment of the
radiotherapy induced skin, soft tissue, and bone adverse le-
sions is complicated, therefore prolonging the healing process
and negatively impacting the patient’s quality of life.5 Topical
interventions to prevent acute radiation dermatitis in head and
neck cancer patients are still not effective and not routinely
used.6 This report follows the recommendations from the
CARE Statement for writing case reports.7
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Table I
CHARACTERISTICS OF THE PATIENTS
Date Event
10/2016 The diagnosis of a meningioma of the right frontal region
11/2016 The neurosurgical local tumor resection
12/2016 Beginning of the Radiotherapy
01/2017 Radiotherapy concluded (60 Gy in total) Patient observed
redness of the scar and pruritus
10/2017 Patient observed redness of the scar and pruritus
11/2017 First ulceration formed on the scalp
11/2017 Subsequent ulceration formed in the next weeks
11/2017 Topical therapy sine effectu
12/2017 Hyperbaric therapy sine effectu
09/01/2018 Initiation of the negative pressure wound therapy
18/01/2018 Significant improvement of the clinical symptoms
II. PATIENT INFORMATION
We describe the case of a female patient, EM, 54 y.o.
who presented with a chronic non-healing wound on her
scalp. The patient was diagnosed with a brain tumor in 2016
(meningioma of the right frontal region) and subsequently
treated with the neurosurgical local resection followed by
the postoperative radiotherapy (60 Gy in 30 fractions over 6
weeks) with good results, no side effects. The oncological
therapeutic effect was satisfactory and at the time of the
ambulatory admission at our department (1/2018) the patient
showed no signs of recurrence of the malignancy.
In October 2017, the patient observed an irritation of
the skin in the postoperative wound (scar) with itching
and redness. Symptoms occurred 10 months after the last
irradiation session. A few weeks later, the lesions transformed
into a single ulcer 2 cm x 4 cm, and in the subsequent weeks
additional ulcerations occurred. Patient reported for a visit in
our office in January 2018.
The patients presented no other pathologies and concomi-
tant diseases, no familial history of neoplasia, nor signs of
cachexia were present. The patient didn’t smoke and use
alcohol.
III. CLINICAL FINDINGS
In January 2018 patient was admitted to the outpatient
Department of the General, Endocrinological Surgery and
Gastrointestinal Oncology. On examination, there were 3
distinct longitudinal ulcers in various size, ranging between 2
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cm and 6 cm in width. Ulcerations increased in depth and size
in 2 preceding weeks exposing the bone with necrosis and
soft tissue inflammation at the lesion borders (Fig. 1). The
skin of the scalp appeared poikilodermic with telangiectases,
hypo- and hyper-pigmentation, and atrophy. A yellowish hue
indicating radiation elastosis was present. The wound bed
was covered with a thick yellowish exudate secreting into
the wound dressing (Fig. 2). The chronic radiation dermatitis
was diagnosed based on a clinical examination and patient’s
medical history.
IV. THERAPEUTIC INTERVENTION
Before the patient presented in our clinic, she underwent
lesion debridement and the dense secretion was evacuated
from the wound bed. Subsequently she was treated with the
standard wound dressings (0,1% octenidine dihydrochloride
and 2% phenoxyethanol wash and alginate wound dressings),
changed 2 times daily without improvement. In December
2017, 6 weeks of hyperbaric therapy (5 x 60 minute sessions
per week with 1,4-1,8 ATA pressure chamber) was intro-
duced, again, without significant improvement.
We decided to introduce the negative pressure wound
therapy (NPWT) with a portable AvelleTM system (Convatec;
UK). The localization of the wounds proved problematic
for the wound dressing application as it was difficult to
provide a reliable seal for the negative pressure therapy
system. We chose a HydrofiberTM wound dressing of 12x21
cm (AvelleTM, Convatec, UK), cut in the middle to reduce its
size and make the application easier. To provide a better seal
for the system, a sealing “frame” of the stoma paste (Stoma-
hesive, Convatec) was put on the surface of the HydrofiberTM
(Fig. 3). The dressing was subsequently applied directly on
the skin of the skull and braced with extra adhesive strips,
especially at the side that was previously cut, to secure it in
place (Fig. 4).
We set the device initially to provide continuous mode
therapy with -80 mmHg vacuum. We changed the wound
dressing every 3 days (3 changes in total). At the first
wound dressing change, we could still observe the signs of
inflammation with pus secretion, erythematous skin irritation
and the oedema of the soft tissues (Fig. 5). After another
3 days the oedema decreased significantly, similarly to the
exudate secretion and the skin erythema. After the last
dressing removal (9 days after the initiation of the NPWT) we
observed no secretion, no soft tissue oedema, and minimal
skin erythema (Fig. 6). Patient did not report pain or itching
(which were moderately severe before). Patient was satisfied
with the outcome and we decided together with the patient to
repeat the course of the hyperbaric therapy where we referred
her. The patient used the standard topical skin care with
hypoallergenic, 10% urea containing emollients thereafter.
V. DISCUSSION
Skin lesions in the course of radiotherapy are a common
side effect, observed in various localizations and regions.8
Every year, 1.2 million cancer patients receive radiation
therapy in the United States only. Late radiation-tissue-injury
Figure 1. The scalp on admission the our department. Radiodermatitis with
multiple skin lesions visible.
Figure 2. The standard gauze wound dresing after dressing change. Notice
the significant amount of exudate.
occurs in an estimated 5-15% of these patients. Tissue injury
can include skin necrosis, which can lead to chronic nonheal-
ing wounds.9 In severe cases, depending on localization, soft
tissue necrosis, inflammation, and infection can also occur.
Craniofacial radiation can lead to severe complicated wounds
and, if used in childhood, to various abnormalities, from soft-
tissue deficiency to osseous deformities.10
One of the effective method of treatment of complicated
wounds is negative pressure wound therapy (NPWT). NPWT
leads to the fast elimination of the septic conditions, im-
proving the tissue vascularization, stimulating the fibroblast
proliferation and migration, managing the wound exudation,
and accelerating wound healing.11 The use of this method has
also been proved to improve the treatment results of severe
surgical infections in neurosurgery.12 One of the earliest
reports describing treatment with vacuum assisted closure
(VAC) therapy on complex cranial wounds was published by
Andrews et al., where two patients with traumatic scalp in-
juries were successfully treated without any complications.13
There are reports in the literature that describe the use of
NPWT in scalp defects with exposed periosteum, and fewer
reports describing defects in periosteum with exposed dura
mater.3, 14
The NPWT is a more effective therapy for bone-exposed
wounds than conventional gauze dressing therapy.15 It can
promote bone-exposed-wounds to heal by increasing collagen
contents and angiogenesis while reducing inflammatory cells
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Figure 3. The HydrofiberTM negative pressure wound dressing with a
sealing stoma paste “frame”.
infiltration, reducing wound infection rates, and inducing an
ordered collagen arrangement.15 In the head region NPWT
can also be effectively used in patients with osteoradionecro-
sis.16
Described NPWT therapies in head and neck wounds
mainly used the standard vacuum devices with canisters.
Many studies in the last years confirmed the effectiveness of
the disposable, canister-less negative pressure wound therapy
system.17 The results of the literature reviews show, that the
portable, canisterless NPWT system meets or exceeds healing
rates previously reported in the literature for canister-based
systems.17 This simple device enhancement offers a more
portable NPWT option, particularly effective in the treatment
of shallow wounds18 and increases patient compliance.
In our case, we used the AvelleTM (Convatec; UK) system,
recently introduced into the medical market.19, 20 AvelleTM
uses HydrofiberTM dressings and the pressure used in therapy
is a continuous -80 mmHg. The very common technical
problem with application of the dressings, also NPWT dress-
ing, is the curvature of the body region. Location of the
NPWT system on the skull was uncertain, therefore, to avoid
decompression, we decided to use the stoma paste. This
modification, improved the seal and prolonged the time be-
tween wound dressing changes as described previously.21, 22
It is most commonly combined with standard “big wound
dressings” based on the polyurethane sponge and canister-
Figure 4. The scalp after introducing the portable negative pressure wound
therapy system
Figure 5. Therapeutic outcome after 2 wound dressing changes and 6 days
of portable NPWT in a continuous mode of -80 mmHg.
based systems. There portable dressing systems may also
be easily cut to obtain the optimal form and size for the
wound bed. It is necessary to remember, that in such case
the exudate collection volume will be lower, and the surgeon
must account for that.
During the therapy we didn’t observed any side-effects
or complications, system was well tolerated by the patient
and lead to the improvement of the wound promoting the
granulation and decreasing the exudate from the wound.
To conclude, the portable NPWT can be successfully used
in cases of complicated skull wounds with soft tissue and
BANASIEWICZ et al. : NPWT IN A CHRONIC RADIATION DERMATITIS OF THE SCALP 11
Figure 6. Therapeutic outcome after 3 wound dressing changes and 9 days
of portable NPWT in a continuous mode of -80 mmHg.
bone defects. However, there are no data to determine the
efficacy of this method relative to other wound healing
methods. It should be remembered, however, that the NPWT
allows to combine various therapeutic methods and poses
a new option for the treatment of difficult no-healing skull
wounds.
VI. INFORMED CONSENT
The patient provided an informed consent for the publi-
cation of this case along with unidentifiable photographic
material.
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